Hepatitis A virus seroprevalence among children and adolescents in a high-burden HIV setting in urban South Africa

© 2022. The Author(s)..

Hepatitis A virus (HAV) infection is one of the most important global causes of viral hepatitis. Recent reviews suggested that HAV endemicity in South Africa could shift from high to intermediate. A hospital-based HAV seroprevalence study was conducted between February 2018 and December 2019 in Pretoria, South Africa. Systematic sampling was performed on children and adolescents (1-15 years) who attended outpatient services. Participants with a known HIV status and valid HAV serology results were included. Of the 1220 participants, the median age was 7 years (IQR: 4-11), with 648 (53.11%) males and 572 (46.89%) females. Of 628 (51.48%) HIV-infected participants, most (329, 71.83%) were both immunologically and virologically controlled or had low-level viremia (74, 16.16%). Almost three-quarters (894, 73.28%) were living in formal dwellings, and just over half (688, 56.39%) had access to clean water sources inside the house. Increasing age was associated with testing HAV IgG-positive (OR 1.25; 95% CI 1.20-1.30, p < 0.001), with 19.8% of participants one year of age compared with 86.7% of participants 15 years of age. This study suggests that South Africa has an intermediate HAV seroprevalence, with rates < 90% by 10 years of age (68.6%). Increased age and informal dwellings are statistically associated with HAV seropositivity, while HIV status does not significantly influence HAV seropositivity.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:12

Enthalten in:

Scientific reports - 12(2022), 1 vom: 30. Nov., Seite 20688

Sprache:

Englisch

Beteiligte Personen:

du Plessis, Nicolette M [VerfasserIn]
Haeri Mazanderani, Ahmad [VerfasserIn]
Motaze, Nkengafac Villyen [VerfasserIn]
Ngobese, Makhosazane [VerfasserIn]
Avenant, Theunis [VerfasserIn]

Links:

Volltext

Themen:

Journal Article
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 02.12.2022

Date Revised 11.01.2023

published: Electronic

Citation Status MEDLINE

doi:

10.1038/s41598-022-25064-x

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM349634793